Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1839]

Breast and cervical cancer rates influenced by HRT, not contraceptive pill

Prof Valerie Beral - University of Oxford, Oxford, UK

Breast and cervical cancer rates influenced by HRT, not contraceptive pill ( Prof Valerie Beral - University of Oxford, Oxford, UK )

Implementing strategies to prevent cancer

Dr Graham Colditz - Washington University in St. Louis, St. Louis, USA

Implementing strategies to prevent cancer ( Dr Graham Colditz - Washington University in St. Louis, St. Louis, USA )

Halving cancer mortality

Prof Richard Peto - University of Oxford, Oxford, England

Halving cancer mortality ( Prof Richard Peto - University of Oxford, Oxford, England )

Editor's Choice for June 2016

Prof Gordon McVie - ecancer Editor in Chief

Editor's Choice for June 2016 ( Prof Gordon McVie - ecancer Editor in Chief )

Editor's ASCO 2016 Roundup

Prof Gordon McVie - ecancer Editor in Chief

Editor's ASCO 2016 Roundup ( Prof Gordon McVie - ecancer Editor in Chief )

Latest in precision cancer medicine

Prof Richard Schilsky - Chief Medical Officer, ASCO

Latest in precision cancer medicine ( Prof Richard Schilsky - Chief Medical Officer, ASCO )

Ten years of letrozole improves survival and quality of life in early-diagnosed...

Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada

Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer. ( Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada )

MyPathway guidance of targeted therapy based on molecular profiles

Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA

MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )

Large disparities found in BCRA testing across ethnicities

Dr Tuya Pal - Moffitt Cancer Center, Tampa, USA

Large disparities found in BCRA testing across ethnicities ( Dr Tuya Pal - Moffitt Cancer Center, Tampa, USA )

Surgery in stage 4 breast cancer increased survival

Prof Atilla Soran - University of Pittsburgh, Pennsylvania, USA

Surgery in stage 4 breast cancer increased survival ( Prof Atilla Soran - University of Pittsburgh, Pennsylvania, USA )

ASCO 2016: Plenary Session Review

Dr Julie Vose - President of ASCO

ASCO 2016: Plenary Session Review ( Dr Julie Vose - President of ASCO )

Extending adjuvant letrozole for 5 years after completing an initial 5 years of...

Dr Paul Goss - Massachusetts General Hospital Cancer Center, Boston, USA

Extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone ( Dr Paul Goss - Massachusetts General Hospital Cancer Center, Boston, USA )

More from ecancer